241/344US=1-B / Farmacologia
Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 237-95. ISBN 978-0-071-142280-3.

AGONISTAS; ANTAGONISTAS; FARMACOS SIMPATICOMIMETICOS; CATECOLAMINAS ENDOGENAS; EPINEFRINA; DOPAMINA; AGONISTAS DOS RECEPTORES ADRENERGICOS; AGONISTAS SELECTIVOS DO RECEPTOR ADRENERGICO; AGONISTAS SIMPATOMIMETICOS DIVERSOS; DROGAS SIMPATOMIMETICAS; ANTAGONISTAS DOS RECEPTORES ADRENERGICOS

242/344US=1-B / Farmacologia
Sanders-Bush E, Mayer SE. 5-Hydroxytryptamine (serotonin): receptor agonists and antagonists. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 297-315. ISBN 978-0-071-142280-3.

5-HIDROXITRIPTAMINA; SEROTONINA; AGONISTAS DOS RECEPTORES; ANTAGONISTAS

243/344US=1-B / Farmacologia
Skidgel RA, Erdos EG. Histamine, bradykinin, and their antagonists. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 629-51. ISBN 978-0-071-142280-3.

HISTAMINA; BRADICININA; ANTAGONISTAS; ANTAGONISTAS DO RECEPTOR H1

244/344US=2 / Biol/Mol
Gülow K, Kaminski M, Krammer PH. Death receptor: the role of CD95/CD95 ligand signaling in apoptosis and cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 3-30. ISBN 978-3-527-31237-5.

RECEPTOR MORTE; SISTEMA CD95; SISTEMA CD95L; SINALIZACAO DA APOPTOSE; CANCER; MAQUINARIA APOPTOTICA; VIA INTRINSECA; VIA EXTRINSECA; MITOCONDRIAS; MECANISMOS DE RESISTENCIA; ANGIOGENESE

245/344US=2 / Biol/Mol
Walczak H, Koschny R, Willen D, Schader MB, Sykora J, Ganten TM, Haas TL. Death receptor: the TRAIL receptor-ligand system: biochemistry of apoptosis induction, therapeutic potential for cancer treatment and physiological function. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 31-92. ISBN 978-3-527-31237-5.

RECEPTOR MORTE; SISTEMA DE RECEPTOR-LIGANTE TRAIL; BIOQUIMICA DA INDUCAO DE APOPTOSE; POTENCIAL TERAPEUTICO; CANCER. TERAPIA; FUNCAO FISIOLOGICA; ATIVACAO DA CASPASE; FAMILIA BCL-2; UBIQUITINA; TERAPIA GENETICA; INFECCAO VIRAL; IMUNOPATOLOGIAS; DOENCAS AUTO-IMUNES; TRANSPLANTE ALOGENICO DE CELULAS-TRONCO HEMATOPOETICAS

246/344US=2 / Biol/Mol
Wajant H. Death receptor: mechanisms of tumor necrosis factor-induced cell death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 93-119. ISBN 978-3-527-31237-5.

RECEPTOR DE MORTE; MORTE CELULAR; FATOR DE NECROSE TUMORAL; APOPTOSE; CANCER. TERAPIA

247/344US=2 / Biol/Mol
Micheau O. Death receptor: cellular FLICE-inhibitory protein: an update. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 120-56. ISBN 978-3-527-31237-5.

CANCER; RECEPTOR MORTE; PROTEINA INIBITORIA DA FLICE; GENE FLIP

248/344US=2 / Biol/Mol
Mehlen P, Lourenço FC. Death receptor: dependence receptors and apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 157-82. ISBN 978-3-527-31237-5.

RECEPTOR DE MORTE; RECEPTORES DE DEPENDENCIA; APOPTOSE; INTEGRINA; TIROSINA QUINASE

249/344US=2-A / Biol/Mol
Rieger J, Weller M. Molecular targets and therapeutics: exploiting apoptosis pathways for glioblastoma therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1033-48. ISBN 978-3-527-31237-5.

ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; VIAS DE APOPTOSE; GLIOBLASTOMA. TERAPIA; PROTEINA P53; FAMILIA BCL-2; FATOR DE CRESCIMENTO DERIVADO DE PLAQUETAS; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FOSFOINOSITIDE-3-KINASE

250/344US=14 / Urologia
Culig Z, Debes JD, Bartsch G, Tindall DJ. Prostate cancer: the role of the androgen receptor in the pathophysiology of prostate cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 31-8. ISBN 978-0-7817-4984-0.

CANCER DE PROSTATA; RECEPTOR ANDROGENO; CANCER DE PROSTATA. FISIOPATOLOGIA; REGULACAO DA TRANSCRICAO; PROTEINAS CO-REGULADORA; APOPTOSE; CICLO CELULAR; ANGIOGENESE; MUTACAO

251/344US=47 / Clín/Medica
Vicent GP, Ballaré C, Zaurin R, Saragueta P, Beato M. Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptors and kinase signaling pathways. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 59-72. ISBN 978-1-57331-699-5.

RATO VIRUS DO TUMOR MAMARIO; RECEPTOR DE PROGESTERONA; CROMATINA; REGULACAO TRANSCRICIONAL; HISTONA H1; QUINASES

252/344US=47 / Clín/Medica
Leader JE, Wang C, Popov VM, Fu M, Pestell RG. Epigenetics and the estrogen receptor. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 73-87. ISBN 978-1-57331-699-5.

EPIGENETICA EO RECEPTOR DE ESTROGENO; RECEPTOR DE ESTROGENO; CICLINA D1; EPIGENETICA; HISTONA; CROMATINA

253/344US=47 / Clín/Medica
Ho SM, Leung YK, Chung I. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 177-93. ISBN 978-1-57331-699-5.

ESTROGENIOS; ANTIESTROGENIOS; RECEPTOR DE ESTROGENO; ANTIESTROGENS; MODULADOR SELETIVO. RECEPTOR DE ESTROGENO; COREGULATORS RECEPTORES NUCLEARES; METILACAO DO DNA; ALCACUZ; APIGENINA; ESTRESSE OXIDATIVO; RISCO DE CANCER DE PROSTATA; TERAPIA HORMONAL

254/344US=47 / Clín/Medica
Migliaccio A, Castoria G, Di Domenico M, Ciociola A, Lombardi M, Falco A, Nanayakkara M, Bottero D, Stasio R, Varricchio L, Auricchio F. Crosstalk between EGFR and extranuclear steroid receptors. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 194-200. ISBN 978-1-57331-699-5.

DIAFONIA ENTRE O EGFR; RECEPTORES DE ESTEROIDES EXTRANUCLEARES; RECEPTOR DE ANDROGENO; RECEPTOR DE ESTROGENO; TRANSDUCAO DE SINAL; FATOR DE CRESCIMENTO EPIDERMICO

255/344US=47 / Clín/Medica
Carruba G. Estrogens and mechanisms of prostate cancer progression. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 201-17. ISBN 978-1-57331-699-5.

ESTROGENIOS; METABOLISMO; RECEPTOR; CANCER DE PROSTATA; PROGRESSAO

256/344US=47 / Clín/Medica
Harkonen PL, Vaananen HK. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 218-27. ISBN 978-1-57331-699-5.

ESTROGENIO; RECEPTOR DE ESTROGENO; MODULADOR SELETIVO DO RECEPTOR DE ESTROGENO; OSTEOCLASTOS; CELULAS DENDRITICAS; MICROGLIA; MACROFAGOS ASSOCIADOS A TUMORES; CANCER DE MAMA; CANCER DE PROSTATA

257/344US=61 / Câncer
Sledge Junior GW, Miller KD, Schneider B, Sweeney CJ. Biochemical resistance: resistance to to antiangiogenic agents. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 391-410. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

ANTIANGIOGENESIS; FACTORES DE CRESCIMENTO ENDOTELIAIS VASCULARES; RECEPTOR DO FATOR ENDOTELIAL VASCULAR; HIPOXIA; INIBIDORES DA TIROSINA QUINASE

258/344US=61 / Câncer
osipo C, O'Regan RM. The role of hormones, growth factors, and oncogenes: resistance to antiestrogens. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 411-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

ANTIESTROGENEO; RESISTENCIA; TAMOXIFEN; CANCER DE MAMA; RECEPTOR DE ESTROGENO; INIBIDORES DE AROMATASE; FACTORES DE CRESCIMENTO

259/344US=61 / Câncer
Mayer IA, Arteaga CL. The role of hormones, growth factors, and oncogenes: herceptin resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 459-67. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

HERCEPTIN; RECEPTOR DE ESTROGENO; RECEPTOR DO FATOR DE CRESCIMENTO EPITELIAL; HER-2; ERB2

260/344US=61 / Câncer
Pinkas J, Teicher BA. The role of hormones, growth factors, and oncogenes: role of TGF-b in tumor progression and metastasis. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 469-89. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1.

FATOR DE CRESCIMENTO TRANSFORMANTE-B; RECEPTOR DO FATOR DE CRESCIMENTO TRANSFORMANTE-B; SMAD; OSTEOCLASTOS; FIBROSE

Primeira | Anterior | Próxima | Última